Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Ficus schwarzii redefined and two new species of Ficus (Moraceae) from Sulawesi (Indonesia) described
Ficus laurifolia (Moraceae) finally in position
Ficus deltoidea: A Potential Alternative Medicine for Diabetes Mellitus
Ficus hispida Bark Extract Prevents Nociception, Inflammation, and CNS Stimulation in Experimental Animal Model
Fidaxomicin: The Newest Addition to the Armamentarium Against Clostridium difficile Infections
Fidaxomicin (Dificid) for Clostridium difficile Infection
Fidaxomicin inhibits toxin production in Clostridium difficile
Fidaxomicin in the Treatment of Clostridium difficile-Associated Diarrhoea
Fidaxomicin %26quot;Chaser%26quot; Regimen Following Vancomycin for Patients With Multiple Clostridium difficile Recurrences
Fidaxomicin Inhibits Clostridium difficile Toxin A-Mediated Enteritis in the Mouse Ileum
Fidaxomicin: A novel agent for the treatment of Clostridium difficile infection
Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection
Fidaxomicin: a new macrocyclic, RNA polymerase-inhibiting antibiotic for the treatment of Clostridium difficile infections
Fidaxomicin: A Macrocyclic Antibiotic for the Management of Clostridium difficile Infection
Fidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian Outcomes
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
Fidaxomicin for treatment of clostridium difficile-associated diarrhea and its potential role for prophylaxis
Fidaxomicin Inhibits Spore Production in Clostridium difficile
Fidaxomicin Therapy in Critically Ill Patients with Clostridium difficile Infection
Fidaxomicin: A Review of Its Use in Patients with Clostridium difficile Infection
Fidaxomicin: a minimally absorbed macrocyclic antibiotic for the treatment of Clostridium difficile infections
Fidaxomicin: New therapy for Clostridium difficile-associated diarrhea
Fidaxomicin: first-in-class macrocyclic antibiotic
Fidaxomicin In Clostridium difficile Infection
Fidaxomycin: The new reference treatment for recurrent Clostridium difficile infections?
Fidaxomicin: A novel macrocyclic antibiotic for the treatment of Clostridium difficile infection
Fidaxomicin, a new treatment for Clostridium difficile infections
Fidaxomicin: A Novel Macrocyclic Antibiotic Approved for Treatment of Clostridium difficile Infection
Fidaxomicin for the Treatment of Clostridium difficile infections
Fidaxomicin (Dificid) for Clostridium Difficile Infection
Fidaxomicin: A Macrocyclic Antibiotic for the Treatment of Clostridium difficile Infection
Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital
Fidaxomicin reduces early toxin A and B production and sporulation in Clostridium difficile in vitro
Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials
Fidaxomicin Attains High Fecal Concentrations With Minimal Plasma Concentrations Following Oral Administration in Patients With Clostridium difficile Infection
Fidaxomicin versus Conventional Antimicrobial Therapy in 59 Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation with Clostridium difficile-Associated Diarrhea
Fidaxomicin Is an Inhibitor of the Initiation of Bacterial RNA Synthesis
Fidaxomicin for Clostridium difficile Infection
Fidaxomicin: a new option for the treatment of Clostridium difficile infection
Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI
Fidaxomicin jams Mycobacterium tuberculosis RNA polymerase motions needed for initiation via RbpA contacts
Fidaxomicin and OP-1118 Inhibit Clostridium difficile Toxin A-and B-Mediated Inflammatory Responses via Inhibition of NF-kappa B Activity
Fidaxomicin versus Vancomycin as a First-Line Treatment for Clostridium difficile-Associated Diarrhea in Specific Patient Populations: A Pharmacoeconomic Evaluation
Fiddling in biodiversity hotspots while deserts burn? Collapse of the Sahara%26apos;s megafauna
Fiddling with memory
Fiddling with the pacemaker: Twiddler's syndrome in a parkinsonian patient
Fiddler crab (Uca spp.) burrows have little effect on surrounding sediment oxygen concentrations
Fiddler crabs (Uca thayeri, Brachyura: Ocypodidae) affect bacterial assemblages in mangrove forest sediments
Fiddlers on the roof: elevation muddles mate choice in fiddler crabs
Fiddling with the proof: the Magpie Fiddler Ray is a colour pattern variant of the common Southern Fiddler Ray (Rhinobatidae: Trygonorrhina)
Fiddler's Neck Accompanied by Allergic Contact Dermatitis to Nickel in a Viola Player
Fiddler crab control of cordgrass primary production in sandy sediments
Fiddler crabs facilitate Spartina alterniflora growth, mitigating periwinkle overgrazing of marsh habitat